Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emerging therapies for the treatment of relapsed or refractory multiple myeloma.

Emerging therapies for the treatment of relapsed or refractory multiple myeloma. Eur J Haematol. 2011 Jan; 86(1):1-15.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.